Dolby Q3 Revenue Misses Consensus, Net Income Halves; Restructuring and Litigation Accrual Weigh on Results

summarizeSummary

Dolby Laboratories reported a disappointing fiscal Q3 with revenue of $305M, missing estimates, and net income halving to $28.6M. A new restructuring plan and a large litigation accrual added to the earnings pressure, while the board boosted the share repurchase authorization by $350M.

check_boxKey Events · Earnings and Guidance · DLB

• Q3 Revenue Miss

  Revenue of $305M fell short of the $312M consensus, with licensing revenue declining 3% YoY to $282.4M, driven by weakness in broadcast, mobile, and PC markets.

• Earnings Plunge

  Net income attributable to Dolby dropped to $28.6M from $46.1M a year ago, as higher operating expenses and a $4.0M restructuring charge compressed margins.

• Restructuring Initiated

  A new restructuring plan was launched in June 2026, incurring $4.0M in severance costs, with expected annual savings of $12M in fiscal 2027, though mostly offset by reinvestment.

• Litigation Accrual

  A $34.5M liability was recorded for an unfavorable litigation judgment assumed in a prior acquisition, fully offset by an indemnification asset, resulting in no net P&L impact.

auto_awesomeAnalysis · DLB · Real Estate & Construction

Dolby's fiscal Q3 revenue fell to $305M, missing the $312M consensus, driven by weaker licensing in broadcast, mobile, and PC markets. Net income dropped to $28.6M from $46.1M a year ago, pressured by a $4.0M restructuring charge and a $34.5M litigation accrual (fully indemnified). The board authorized a $350M increase to the buyback program, bringing total capacity to ~$427M, signaling confidence but also highlighting the earnings shortfall.